Valproate-induced hyperammonemic encephalopathy enhanced by topiramate and phenobarbitone: A case report and an update

Annals of Indian Academy of Neurology

Volumn 13, Issue 2, 2010, Pages 145-147

  Vivekanandan, S ^a   Nayak, S Dinesh ^a  

^a Global Hospitals and Health City ^*  (India)

Author keywords

Encephalopathy; hyperammonemia; phenobarbitone; topiramate; valproate

Indexed keywords

AMMONIA; CARBAMAZEPINE; CARNITINE; CLONAZEPAM; ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; TOPIRAMATE; UREA; VALPROIC ACID;

AMMONIA BLOOD LEVEL; APPETITE DISORDER; ARTICLE; BRAIN DISEASE; CASE REPORT; CHILD; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; GLIOSIS; HUMAN; HYPERAMMONEMIA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; SEIZURE; SLEEP WAKING CYCLE; UREA BLOOD LEVEL;

EID: 77954226162     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.64638     Document Type: Article

References (18)

1. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifi able epilepsy: An unblinded randomised controlled trial. Lancet 2007;369:1016-1026 (Pubitemid 46436125)
2. Duarte J, Macias S, Coria F, Fernandez E, Claveria LE. Valproate induced coma: Case report and literature review. Ann Pharmacother 1993;27:582-583
3. Gomceli YB, Kutlu G, Cavdar L, Sanivar F, Inan LE. Different clinical manifestations of hyperammonaemic encephalopathy. Epilepsy Behav 2007;10:583-587
4. Zaccara G, Paganini M, Campostrini R, Moroni F, Valenza T, Messori A, et al. Effect of associated antiepileptic treatment on valproate-induced hyperammonemia. Ther Drug Moni 1985;7: 185-190
5. Hamer HM, Knake S, Schomburg U, Rosenow F. Valproateinduced hyperammonemic encephalopathy in the presence of topiramate. Neurology 2000;54:230-232
6. Cheung E, Wong V, Fung CW. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: Case report. J Child Neurol 2005;20:157-160
7. Oechsner M, Steen C, Sturenberg HJ, Kohlschütter A. Hyperammonemic encephalopathy after initiation of valproate therapy in unrecognized ornithine transcarbamylase defi ciency. J Neurol Neurosurg Psychiatry 1998;64:680-682
8. Scriver CR, Beaudet al, Sly Ws, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill Medical Publication division; Vol.2, 2001. p. 2165-2193
9. Panda S, Radhakrishnan K. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure. J Assoc Physicians India 2004;52:746-748
10. Rath A, Naryanan TJ, Chowdhary GV, Murthy JM. Valproateinduced hyperammonemic encephalopathy with normal liver function. Neurol India 2005;53:226-228
11. Mehndiratta MM, Mehndiratta P, Phul P, Garg S. Valproate induced non hepatic hyperammonaemic encephalopathy (VNHE): A study from tertiary care referral university hospital, north India. J Pak Med Assoc 2008;58:627-631
12. Heron B, Gautier A, Dulac O, Ponsot G. Biotinidase defi ciency: Progressive encephalopathy curable with biotin. Arch Fr Pediatr 1993;50:875-878
13. Walser M. Role of urea production, ammonium excretion, and amino acid oxidation in acid base balance. Am J Physiol 1986;250:181-188
14. Lundberg R, Nergadh A, Borrus IO. Plasma concentration of valproate drug maintenance therapy in epileptic children. J Neurol 1982;228:133-141
15. DeWolfe JL, Knowlton RC, Beasley MT, Cofield S, Faught E, Limdi NA. Hyperammonemia following intravenous valpraote loading. Epilepsy Res 2009;85:65-71.
16. Lokrantz CM, Eriksson B, Rosén I, Asztely F. Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam. Acta Neurol Scand 2004;109:297-301.
17. Beversdorf C, Allen C, Nordgren R. Valproate induced encephalopathy treated with L-Carnitine in an adult. J Neurol Neurosurg Psychiatry 1996;61:211.
18. De Vivo DC, Bohan TP, Coulter DL, Dreifuss FE, Greenwood RS, Nordli DR Jr, et al. L-Carnitine supplementation in childhood epilepsy: Current perspectives. Epilepsia 1998;39:1216-1225